343 related articles for article (PubMed ID: 7651644)
1. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
4. Current management of malignant germ cell tumor of the ovary.
Aziz MF
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
[TBL] [Abstract][Full Text] [Related]
5. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C
Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313
[TBL] [Abstract][Full Text] [Related]
6. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors].
Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456
[TBL] [Abstract][Full Text] [Related]
8. Childhood malignant ovarian germ cell tumors: a monoinstitutional experience.
Terenziani M; Massimino M; Casanova M; Cefalo G; Ferrari A; Luksch R; Spreafico F; Polastri D; Fontanelli R; Piva L; Fossati-Bellani F
Gynecol Oncol; 2001 Jun; 81(3):436-40. PubMed ID: 11371135
[TBL] [Abstract][Full Text] [Related]
9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
10. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
11. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
12. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and prognostic factors of malignant ovarian teratoma].
Jin FM; Zhu GZ; Feng YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088
[TBL] [Abstract][Full Text] [Related]
14. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
[TBL] [Abstract][Full Text] [Related]
15. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
17. [Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases].
Baranzelli MC; Patte C; Bouffet E; Quintana E; Portas M; Vannier JP; Thyss A; Schmitt C; Flamant F
Contracept Fertil Sex; 1999 Feb; 27(2):133-9. PubMed ID: 10191568
[TBL] [Abstract][Full Text] [Related]
18. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
[TBL] [Abstract][Full Text] [Related]
19. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary.
Nishio S; Ushijima K; Fukui A; Fujiyoshi N; Kawano K; Komai K; Ota S; Fujiyoshi K; Kamura T
J Obstet Gynaecol Res; 2006 Aug; 32(4):416-21. PubMed ID: 16882268
[TBL] [Abstract][Full Text] [Related]
20. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]